Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 1, 2021 10:13 AM 4 min read

Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Receives FDA Approval For COVID-19 Vaccine

by Lisa Levin Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Following the market opening Monday, the Dow traded up 1.91% to 31,522.98 while the NASDAQ rose 1.72% to 13,419.71. The S&P also rose, gaining 1.75% to 3,877.99.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 28,605,930 cases with around 513,090 deaths. India confirmed a total of at least 11,112,240 confirmed cases and 157,150 deaths, while Brazil reported over 10,551,250 COVID-19 cases with 254,940 deaths. In total, there were at least 114,193,910 cases of COVID-19 worldwide with over 2,532,750 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Energy shares rose 3.5% on Monday. Meanwhile, top gainers in the sector included Aemetis, Inc. (NASDAQ:AMTX), up 50%, and PBF Logistics LP (NYSE:PBFX), up 10%.


In trading on Monday, real estate shares rose by just 1.1%.


Top Headline

Johnson & Johnson's (NYSE:JNJ) single-shot coronavirus vaccine candidate has been cleared as the third vaccine in the U.S. for emergency use, a day after it received the unanimous backing of an independent Food and Drug Administration expert panel. The CDC Advisory Panel also voted to recommend the company’s vaccine for adults over 18.

J&J's vaccine has been issued authorization to prevent COVID-19 caused by SARS-CoV2, allowing it to be distributed in the U.S. for use in individuals 18 years of age and older, the FDA said .

 

Equities Trading UP


Morphic Holding, Inc. (NASDAQ:MORF) shares shot up 71% to $62.00 after the company reported FY20 sales of $45 million, up from $17 million year over year. The company also reported "positive" interim results from single ascending dose Phase 1 clinical trial of MORF-057.


Shares of Aemetis, Inc. (NASDAQ:AMTX) got a boost, shooting 48% to $14.57 after the company disclosed five-year plan targeting $1 billion of revenue by 2025.


electroCore, Inc. (NASDAQ:ECOR) shares were also up, gaining 58% to $3.43 after the company announced an Exclusive Distribution Agreement with Medistar following regulatory approval in Australia.

Check out these big movers of the day


Equities Trading DOWN

Athenex, Inc. (NASDAQ:ATNX) shares tumbled 53% to $5.63 after the company's marketing application for oral paclitaxel to treat metastatic breast cancer was denied by the FDA.

 

Shares of Ontrak, Inc. (NASDAQ:OTRK) were down 47% to $31.53 after the company issued FY21 sales guidance below analyst estimates.


Commodities


In commodity news, oil traded up 1.1% to $62.20, while gold traded up 0.7% to $1,740.70.


Silver traded up 1.7% Monday to $26.89 while copper rose 1.2% to $4.1425.


Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 1.4%, the Spanish Ibex Index rose 1% and the German DAX 30 gained 0.9%. Meanwhile, the French CAC 40 rose 1.3%, London’s FTSE 100 rose 1.3% and Italy’s FTSE MIB climbed 1.2%.

The IHS Markit Eurozone manufacturing PMI was revised slightly higher to 57.9 in February from a preliminary estimate of 57.7. Spain’s manufacturing PMI climbed to 52.9 in February from 49.3 a month ago, while German manufacturing PMI increased to 60.7 in February from 57.1 in January. French manufacturing PMI climbed to 56.1 in February from 51.6 in January.


Economics


The IHS Markit manufacturing PMI was revised higher to 58.6 in February from a preliminary reading of 58.5.


The ISM manufacturing PMI climbed to 60.8 in February from 58.7 in January.


Construction spending increased 1.7% to an annual rate of $1.52 trillion in January.


The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.


Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 2:00 p.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Morning Market Update
AMTX Logo
AMTXAemetis Inc
$1.55-1.27%
Overview
CRMD Logo
CRMDCormedix Inc
$7.802.90%
ECOR Logo
ECORelectroCore Inc
$5.22-2.43%
JNJ Logo
JNJJohnson & Johnson
$238.34-0.13%
OTRK Logo
OTRKOntrak Inc
$0.0601-84.0%

CorMedix Inc. (NASDAQ:CRMD) was down, falling 42% to $8.64 after the FDA has issued a Complete Response Letter for CorMedix’s marketing application seeking approval for DefenCath (taurolidine/heparin catheter lock solution) for catheter-related bloodstream infections. FDA noted concerns at the third-party manufacturing facility after reviewing records, though the agency did not specify the issues.

AMTX Logo
AMTXAemetis Inc
$1.55-1.27%
Overview
CRMD Logo
CRMDCormedix Inc
$7.802.90%
ECOR Logo
ECORelectroCore Inc
$5.22-2.43%
JNJ Logo
JNJJohnson & Johnson
$238.34-0.13%
OTRK Logo
OTRKOntrak Inc
$0.0601-84.0%
Comments
Loading...